F28Safety and clinical outcomes of abiraterone acetate (aa) after docetaxel (doc) in octogenarians with metastatic castration-resistant prostate cancer (mcrpc)
Caffo, O., Maines, F., De Giorgi, U., Fratino, L., Lo Re, G., Zagonel, V., D'Angelo, A., Donini, M., Verderame, F., Ratta, R., Procopio, G., Campadelli, E., Massari, F., Gasparro, D., Ermacora, P., MeVolume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv341.28
Date:
October, 2015
File:
PDF, 33 KB
english, 2015